Merck applied for US emergency use authorization for COVID-19 pill

by 24USATVOct. 12, 2021, 12:50 a.m. 21
-

The treatment, molnupiravir, cut the rate of hospitalization and death by 50% in a trial of mild-to-moderately ill patients who had at least one risk factor for the disease, according to data released

Tags:
-

Related Articles

NEWS

Climate deal faces challenges over spending

by 24USATVOct. 19, 2021, 9:50 p.m.2
NEWS

Michigan city facing new toxic water crisis

by 24USATVOct. 19, 2021, 9:50 p.m.2
NEWS

Dancers, La Palma volcano and COVID: World in Photos, Oct. 19

by 24USATVOct. 19, 2021, 5:50 p.m.2
NEWS

75th NBA season tips off Tuesday

by 24USATVOct. 19, 2021, 5 p.m.2
NEWS

China reportedly tests a nuclear-capable hypersonic missile

by 24USATVOct. 19, 2021, 3:50 p.m.2
NEWS

Remembering the life of Colin Powell

by 24USATVOct. 19, 2021, 2:50 p.m.2